Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Medy Tox Inc (086900 KS)
Watchlist
66
Analysis
Health Care
•
South Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
28 Mar 2019 21:42
Smartkarma’s Week That Was in JP/KR: Semiconductor Warnings, Exit of Chairman Cho, & 청년수당
In the past week, there were earnings warnings from three major players in the global semiconductor sector, including Samsung Electronics (005930...
Douglas Kim
Follow
797 Views
Share
bullish
•
Cross Asset Strategy
•
27 Nov 2018 05:23
EM Health Care: Late Cycle Rotation
Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...
Steven Holden
Follow
475 Views
Share
bullish
•
Hugel Inc
•
12 May 2026 08:30
Hugel Inc (145020 KS): Record High 1Q Earnings; Global Expansion to Accelerate Growth Ahead
Hugel reported strong 1Q26 results, with 22% operating profit growth on 30% revenue growth. The company aims for 2028 revenue of KRW900B while...
Tina Banerjee
Follow
124 Views
Share
bullish
•
Thematic (Sector/Industry)
•
17 Jan 2018 15:06
KRX 300 - Selection Process Summary & Current Mood
Feb 5 is our big day. On Feb 5 the KRX will announce more details about this highly anticipated and much awaited new KOSPI+KOSDAQ integrated...
Sanghyun Park
Follow
772 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Nov 2017 21:53
Summary of KOSDAQ 150 December Reshuffle & Rebalancing
It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...
Sanghyun Park
Follow
746 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x